SCHIZOPHRENIA THERAPEUTIC MARKET ANALYSIS

Schizophrenia Therapeutic Market, by Treatment (First Generation Antipsychotic Drugs and Second Generation Antipsychotic Drugs), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI2468
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Schizophrenia Therapeutic Market Key Players

Key players operating in the global schizophrenia therapeutic market include, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Johnson & Johnson, Pfizer, Sandoz Canada Inc., Intas Pharmaceuticals, Novartis AG, Otsuka Pharmaceuticals, Alkermes, Allergan (Forest Labs), and Sumitomo Dainippon Pharma.